Purchase Order W911QY17P0354
Award Date
9/25/17
Potential Completion Date
9/24/18
Potential Value
$2K
Funding Federal Agency
Medical Command
Contracting Federal Agency
ACC Aberdeen Proving Ground
Awardee
Ajinomoto Althea, Inc.
Ultimate Awardee
Ajinomoto Co., Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Ajinomoto Althea, Inc. is for stability testing of Hantaan and Puumala deoxyribonucleic acid (DNA) plasmids, in support of research conducted by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The contract has a ceiling value of $26,700.00 and a period of performance through September 23, 2024. The contract was awarded on a sole-source basis, as Ajinomoto Althea is currently...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Pacific to Alfresa Corporation, a Japan-based medical device and life sciences company. The order, worth $3,405.88, is for the supply of various laboratory reagents, diagnostic equipment, and consumable medical supplies to support U.S. military operations and medical treatment facilities in the Pacific region. Alfresa Corporation holds several indefinite delivery contracts (IDVs) with the DLA...
This federal contract award, with an ID of SPE8EQ24D0004|SPE8EQ25F0008, was issued by the Defense Logistics Agency (DLA) Troop Support Pacific to Alfresa Corporation, a Japan-based medical device and life sciences company, to provide medical reagents, laboratory equipment, diagnostic supplies, and preventive maintenance services to U.S. military facilities in the Pacific region. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,764,938.75 and an ultimate completion...
The U.S. Defense Logistics Agency (DLA) Troop Support Pacific awarded a Firm Fixed Price Delivery Order contract to Alfresa Corporation, a Japanese medical device and life sciences company, for the supply of laboratory reagents, diagnostic equipment, and consumable supplies to support U.S. military operations and medical treatment facilities in the Pacific region. The contract, with a ceiling value of $10,820.14, has an ultimate completion date of October 19, 2022. Alfresa Corporation is an...
<p>The Defense Logistics Agency Troop Support Pacific awarded a $121 firm fixed price delivery order contract to Alfresa Corporation of Japan on August 24, 2023 to provide four clinics with reagents through August 30, 2023. The contract has no set-aside designation and was awarded under the agency's open market procurement procedures to support its operations in Japan. Alfresa Corporation will deliver the requested medical supplies directly to the specified clinics to support their work.</p>
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Pacific to Alfresa Corporation, a Japan-based supplier of medical devices, laboratory equipment, reagents, and consumable supplies. The $1,182.82 contract is for the delivery of reagents to support U.S. military operations in Japan, with a period of performance through January 31, 2024. Alfresa Corporation has held multiple indefinite delivery contracts with DLA Troop Support Pacific,...
<p>This delivery order for medical reagents was awarded by the Defense Logistics Agency Troop Support Pacific to Alfresa Corporation of Japan. The firm fixed price contract has a potential value of eight hundred six dollars and requires delivery by February 25, 2020. No set-aside provisions were applied to this procurement for the Defense Logistics Agency, which supports various Department of Defense programs in the Pacific region through acquisition and logistics services.</p>
Alfresa Corporation has been awarded a firm fixed price delivery order against one of its medical reagents indefinite delivery contracts with the Defense Logistics Agency Troop Support Pacific. The $4,800.06 order is for the delivery of medical reagents to support operations in Japan, with work expected to be completed by January 31, 2023. Alfresa holds five IDVs with DLA Troop Support Pacific for supplying medical reagents, laboratory supplies, and related products to U.S. military facilities...
The Defense Logistics Agency Troop Support Pacific awarded a $539 firm fixed price delivery order contract to Alfresa Corporation of Japan on June 22, 2022. The contract is for the delivery of ALFRESA REAGENTS DIEGO GARC to an unspecified location in Japan, with a completion date of June 22, 2022. As no set-aside designation was used, the award was made on an unrestricted basis. Alfresa Corporation will serve as the prime contractor to supply the requested reagents to DLA Troop Support...
This federal contract award, with ID SPE8EQ24D0005|SPE8EQ25F0003, was issued by the Defense Logistics Agency (DLA) Troop Support Pacific to Alfresa Corporation, a Japan-based medical device and life sciences company. The $33,868.45 firm-fixed-price delivery order contract is for the provision of medical reagents to U.S. military facilities in the Pacific region, including Naval Hospital Yokosuka, Iwakuni, Sasebo, and Atsugi, as well as Diego Garcia. This contract is part of Alfresa's larger...